Analystreport
Agile Therapeutics Inc (NASDAQ: AGRX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
Last agile therapeutics earnings: 8/3 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
| IMPACT SNAPSHOT | EVENT TIME: | AGRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AGRX alerts
AGRX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGRX alerts
High impacting AGILE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics
AGRX
NEWS
NEWS
- Agile Therapeutics beats by $0.01 [Seeking Alpha][Seeking Alpha]
- Agile Therapeutics Reports Second Quarter 2018 Financial Results[GlobeNewswire]
- FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request[GlobeNewswire]
- Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance[GlobeNewswire]
- Agile Therapeutics Inc (NASDAQ: AGRX) had its price target lowered by analysts at Royal Bank of Canada to $3.00. They now have an "outperform" rating on the stock.[MarketBeat]
- More
AGRX
SEC Filings
SEC Filings
- 8/3/18 - Form 10-Q
- 8/3/18 - Form 8-K
- 7/26/18 - Form 4
- AGRX's page on the SEC website
- More